Skip to main content

Moderna; In Case Retail Investors Have Gotten Ahead Of Themselves

Shares of Moderna spiked 20% Monday, but some wondered why. Didn't we know about their COVID-19 vaccine two weeks ago? What to consider now if you're long.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.